Lev PR - Search Results

1

High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.

De Luca G, Lev PR, Camacho MF, Goette NP, Sackmann F, Castro Ríos MA, Moiraghi B, Cortes Guerrieri V, Bendek G, Carricondo E, Enrico A, Vallejo V, Varela A, Khoury M, Gutierrez M, Larripa IB, Marta RF, Glembotsky AC, Heller PG. De Luca G, et al. Among authors: lev pr. Front Immunol. 2023 Nov 16;14:1161832. doi: 10.3389/fimmu.2023.1161832. eCollection 2023. Front Immunol. 2023. PMID: 38035089 Free PMC article.

2

Variation of PDGF, TGFbeta, and bFGF levels in essential thrombocythemia patients treated with anagrelide.

Lev PR, Marta RF, Vassallu P, Molinas FC. Lev PR, et al. Am J Hematol. 2002 Jun;70(2):85-91. doi: 10.1002/ajh.10091. Am J Hematol. 2002. PMID: 12111780 Free article. Clinical Trial.

3

Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.

Marta R, Goette N, Lev P, Heller P, Kornblihtt L, Vassallú P, Glembotsky A, Pirola C, Molinas F. Marta R, et al. Haematologica. 2004 Jun;89(6):657-63. Haematologica. 2004. PMID: 15194532

4

Normal platelets possess the soluble form of IL-6 receptor.

Marta RF, Goette NP, Lev PR, Chazarreta CD, Pirola CJ, Molinas FC. Marta RF, et al. Among authors: lev pr. Cytokine. 2005 Jan 7;29(1):13-7. doi: 10.1016/j.cyto.2004.09.003. Cytokine. 2005. PMID: 15579373

5

PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.

Lev PR, Salim JP, Kornblihtt LI, Pirola CJ, Marta RF, Heller PG, Molinas FC. Lev PR, et al. Am J Hematol. 2005 Feb;78(2):155-7. doi: 10.1002/ajh.20268. Am J Hematol. 2005. PMID: 15682418 Free article.

6

JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status.

Heller PG, Lev PR, Salim JP, Kornblihtt LI, Goette NP, Chazarreta CD, Glembotsky AC, Vassallu PS, Marta RF, Molinas FC. Heller PG, et al. Among authors: lev pr. Eur J Haematol. 2006 Sep;77(3):210-6. doi: 10.1111/j.1600-0609.2006.00688.x. Eur J Haematol. 2006. PMID: 16923108

7

Platelets possess functional TGF-beta receptors and Smad2 protein.

Lev PR, Salim JP, Marta RF, Osorio MJ, Goette NP, Molinas FC. Lev PR, et al. Platelets. 2007 Feb;18(1):35-42. doi: 10.1080/09537100600800743. Platelets. 2007. PMID: 17365852

8

Diverse Mpl expression pattern among pedigrees with inherited thrombocytopenia: potential diagnostic and therapeutic implications.

Heller PG, Glembotsky AC, Goette NP, Marta RF, Lev PR, Molinas FC. Heller PG, et al. Among authors: lev pr. J Thromb Haemost. 2008 Dec;6(12):2215-7. doi: 10.1111/j.1538-7836.2008.03159.x. Epub 2008 Sep 23. J Thromb Haemost. 2008. PMID: 18823338 Free article. No abstract available.

9

Dysregulation of stromal derived factor 1/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia.

Salim JP, Goette NP, Lev PR, Chazarreta CD, Heller PG, Alvarez C, Molinas FC, Marta RF. Salim JP, et al. Among authors: lev pr. Br J Haematol. 2009 Jan;144(1):69-77. doi: 10.1111/j.1365-2141.2008.07428.x. Epub 2008 Nov 1. Br J Haematol. 2009. PMID: 19006565 Free article.

10

Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.

Glembotsky AC, Korin L, Lev PR, Chazarreta CD, Marta RF, Molinas FC, Heller PG. Glembotsky AC, et al. Among authors: lev pr. Eur J Haematol. 2010 May;84(5):398-405. doi: 10.1111/j.1600-0609.2010.01421.x. Epub 2010 Jan 22. Eur J Haematol. 2010. PMID: 20113333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page